Close Menu

NEW YORK ─ The US Food and Drug Administration on Friday reissued an Emergency Use Authorization for the Thermo Fisher Scientific TaqPath COVID-19 Combo Kit and expanded it to include an additional sample collection kit provided by Austin, Texas-based Everlywell as well as a new workflow.

In March, Thermo Fisher's test was the second commercial diagnostic assay to be granted EUA.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.